1-3 of 3
Vassilis G. Gorgoulis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Novel Proteasome Inhibitors Carfilzomib and Oprozomib Induce Milder Degenerative Effects Compared To Bortezomib When Administered Via Oral Feeding In An In Vivo Drosophila Experimental Model: A Biological Platform To Evaluate Safety/Efficacy Of Proteasome Inhibitors

Evangelos Terpos, Eleni N. Tsakiri, Efstathios Kastritis, Tina Bagratuni, Vassilis G. Gorgoulis, Ioannis P. Trougakos, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2013) 122 (21): 1930.
https://doi.org/10.1182/blood.V122.21.1930.1930
Published: 2013
Journal Articles

Molecular Analyses Of The Effects Induced By Orally Administered Bortezomib In Drosophila Flies: A Novel In Vivo Experimental Platform To Screen For The Tissue- and Age-Dependent Effects Of Proteasome Inhibitors

Eleni N. Tsakiri, Evangelos Terpos, Gerasimos P. Sykiotis, Issidora S. Papassideri, Vassilis G. Gorgoulis, Dirk Bohmann, Meletios A. Dimopoulos, MD, Ioannis P. Trougakos
Journal: Blood
Blood (2013) 122 (21): 2910.
https://doi.org/10.1182/blood.V122.21.2910.2910
Published: 2013
Journal Articles

Is exclusive Skp2 targeting always beneficial in cancer therapy?

Marilena Koutsami, Georgia Velimezi, Athanassios Kotsinas, Konstantinos Evangelou, Athanassios G Papavassiliou, Christos Kittas, Vassilis G. Gorgoulis
Journal: Blood
Blood (2008) 112 (12): 4777–4779.
https://doi.org/10.1182/blood-2008-06-161802
Published: 2008
Includes: Supplemental data